New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease

New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease

Abstract Cytomegalovirus (CMV) infection can have both direct and indirect effects after solid-organ transplantation, with a significant impact on transplant outcomes. Prevention strategies decrease the risk of CMV disease, although CMV still occurs in up to 50% of high-risk patients. Ganciclovir (G...

Full description

Bibliographic Details
Main Authors: Camille Nelson Kotton, Nassim Kamar
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Infectious Diseases and Therapy
Subjects:
Organ transplantation
Prevention
Resistant CMV
Refractory CMV
Letermovir
Maribavir
Online Access:https://doi.org/10.1007/s40121-022-00746-1

Internet

https://doi.org/10.1007/s40121-022-00746-1

Similar Items